As of 2025-10-02, the Fair Value of Prime Medicine Inc (PRME) is -8.26 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 5.59 USD, the upside of Prime Medicine Inc is -247.73%.
With the market price of 5.59 USD and our fair value calculation, Prime Medicine Inc (PRME) is not a good investment. Investing in PRME stocks now will result in a potential loss of 247.73%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -3.41 | -165.37 | -121.82 | -198.13 | -195.88 | -136.92 |
| YoY growth | -34.78% | -4,749.56% | 26.33% | -62.64% | 1.14% | -963.90% |
| Market Cap (mil) | 977.47 |
| P/E | |
| Forward P/E |
| EPS | -1.65 |
| Avg earnings growth rate | -963.90% |
| TTM earnings |